Another study indicates that AFP-L3% with a value of >50% correctly identified 96% of patients with various types of NSGCTs, i.e., embryonal carcinoma (n = 9), yolk sac tumour (n = 4), a mixed type without seminomas (n = 5) and a mixed type with seminoma (n = 7), irrespective of the AFP level in serum [109]. This evidence concerns the gene AFP and embryonal carcinoma.